Navigation Links
ADVENTRX Pharmaceuticals Provides Update on ANX-514
Date:2/15/2011

SAN DIEGO, Feb. 15, 2011 /PRNewswire/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today provided an update on its product candidate, ANX-514, its polysorbate 80-free formulation of docetaxel.  The U.S. Food and Drug Administration (FDA) determined that ANX-514 could not be approved based on the findings from the bioequivalence study of ANX-514 (Study 514-01) and that additional development activities would be required for approval.  ADVENTRX met with the FDA to discuss required activities.  

"We are pleased with the outcome of our discussion with FDA, at which the conceptual design of a single, additional clinical study that could support approval of ANX-514 was discussed.  We believe the study requested by the Agency is reasonable, and we are developing a study protocol for submission to the FDA.  We will provide a further update after receiving feedback from FDA on the protocol," said Brian M. Culley, Chief Executive Officer of ADVENTRX.  

"We have netted over $50 million from financings during the last 18 months and we intend to use this capital to continue to develop ANX-514, to pursue acquisition opportunities, such as our recently-announced agreement to acquire SynthRx, and to prepare for the commercial launch of Exelbine™, should it be approved," Mr. Culley continued.  

ADVENTRX met with the FDA to discuss ANX-514.  Prior to the meeting, ADVENTRX submitted to the FDA a data package based on Study 514-01 and published literature.  ADVENTRX believes the data package supports the conclusion that comparable clinical outcomes can be expected following treatment with either ANX-514 or Taxotere®, despite Study 514-01 not demonstrating bioequivalence, its primary endpoint, using an unscaled bioequivalence methodology.  In particular, the data package concludes that unbound docetaxel concentrations
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ADVENTRX Signs Definitive Agreement to Acquire SynthRx Inc.
2. ADVENTRX to Provide Update Regarding Pipeline Expansion Efforts
3. ADVENTRX Pharmaceuticals to Present at the 13th Annual BIOCEO & Investor Conference on February 15
4. ADVENTRX Pharmaceuticals Receives PDUFA Date for Exelbine™ NDA
5. ADVENTRX Pharmaceuticals Announces Closing of $22.5 Million Financing
6. ADVENTRX Pharmaceuticals Announces Capital Raise of $22.5 Million
7. ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics
8. ADVENTRX Pharmaceuticals to Present at the 4TH Annual OneMedForum Business Development and Investment Conference on January 11
9. ADVENTRX Requests Meeting with FDA to Discuss ANX-514 Study
10. ADVENTRX Reports Third Quarter Financial Results
11. ADVENTRX to Present at the Wall Street Analyst Forum 21st Annual Institutional Investor Conference on November 11
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014   Memorial Hermann Health ... Cancer Center today announced a new partnership to provide ... of community breast care centers in the greater ... MD Anderson will become the exclusive provider of professional breast ... centers, located in Memorial City, The Woodlands ...
(Date:8/21/2014)... , Aug. 21, 2014  Publicis Groupe customer ... , Managing Partner and Healthcare Industry Group Leader, has ... which recognizes the most inspiring people in the life-sciences ... in research and development, marketing, technology, creativity, strategy and ... 2006 as a partner in its leading Rosetta Consulting ...
(Date:8/21/2014)... , N.Y. and HAMBURG, Germany , ... announced it is collaborating with Deutsches Elektronen-Synchrotron ( DESY ... Germany , to speed up management and storage ... Big Data and Analytics architecture based on IBM ... per second of data at peak performance and help ...
Breaking Medicine Technology:Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4Shannon Hartley Shines in PharmaVOICE 100 2DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3
... -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ... outsourcing company with operations in China and the United ... for the second quarter of 2011 after the New ... (which will be Thursday morning, August 11, 2011 Shanghai ...
... For the fourth year, the Fondation,Médéric Alzheimer and ... psychosocial,interventions for people with dementia and their carers. The,purpose ... share best,practices. Applications can be submitted from today 19 ... . Psychosocial research involves or relates to ...
Cached Medicine Technology:WuXi PharmaTech Schedules Second-Quarter 2011 Earnings Release 24th Alzheimer's Awards Announced in Search of Global Solutions for Better Dementia Care 2
(Date:8/21/2014)... 2014 Top10BestSEOHosting.com has recently compared ... iPage ( http://www.top10bestseohosting.com/go/iPage/ ) is one of the ... , The manager of Top10BestSEOHosting.com states, “It is ... Actually, these companies have outperformed their competitors on ... People can get the best web hosting at ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 An increasing ... a taxpayer that their federal tax payment is being ... appears to come from the IRS, “tax@irs.gov”, it’s actually ... provide personal and financial information. , While similar scams ... an uptick in phishing activity is occurring right now. ...
(Date:8/21/2014)... Patients with advanced laryngeal cancer appear to have ... than nonsurgical chemoradiation. , Author: Uchechukwu C. Megwalu, ... at Mount Sinai, New York, and colleagues. , ... cancer are diagnosed each year and squamous cell ... tumors. Prior to 1991, total surgical removal of ...
(Date:8/21/2014)... at a low or very low birth weight may ... diabetes. The findings, which appear in Diabetes Care ... type 2 diabetes in African American populations, which has ... from Boston University,s Slone Epidemiology Center followed more than ... over the course of 16 years, analyzing characteristics such ...
(Date:8/21/2014)... 21, 2014 (HealthDay News) -- Among seniors, dimming vision ... The study involved more than 2,500 people, aged 65 to ... and again two, six and eight years later. Vision ... person,s risk of death during the study period, the researchers ... researchers led by Sharon Christ of Purdue University in West ...
Breaking Medicine News(10 mins):Health News:iPage Reviews Unveiled Online At Top10BestSEOHosting.com 2Health News:Beware Of Phony “Tax Payment Rejected” IRS Emails 2Health News:Surgery associated with better survival for patients with advanced laryngeal cancer 2Health News:Low birth weight linked to higher incidence of type 2 diabetes in African American women 2Health News:Failing Vision Tied to Shorter Lifespans for Seniors 2
... Service Helps Providers Better Partner with Patients in ... Deepening its commitment to empowering patients and ... & Associates, LLC, a firm of strategic healthcare ... has established a new, first-of-its-kind service called Patient ...
... New Orleans, LA Xiaoming, Xu, PhD, Associate ... Health Sciences Center New Orleans School of Dentistry, ... of $1.77 million over four years by the ... fluoride-releasing, and bioactive dental materials including dental composites, ...
... Fla.--A new blood test used in combination with a ... of prostate cancer diagnosis, and could eliminate tens of ... according to a study led by researchers at Dana-Farber ... American Society of Clinical Oncology in Orlando, Fla., William ...
... Estimator(TM) Gives Patients Visibility into Treatment Costs before ... with the high number of uninsured and underinsured ... in consumer-driven health plans, such as Health Savings ... their own healthcare costs. As a result, hospitals ...
... Now, no matter when a patient with the ... a Spanish-speaking representative is available to help. Insulet Corporation ... insulin pump technology with its OmniPod System, has expanded ... a day, seven days a week."Managing diabetes is a ...
... NEW YORK, May 28 A new history of shock ... They Don,t Want You to Know About Shock Treatment" ( ... the Food and Drug Administration,s failure to investigate the devices ... is timely due to the FDA,s recent decision to call ...
Cached Medicine News:Health News:Gullapalli & Associates Launches First-of-Its-Kind Patient Centered CME(TM) (PCCME(TM)) Service, Names Dora Ochsenbein Manager of Educational Planning 2Health News:Gullapalli & Associates Launches First-of-Its-Kind Patient Centered CME(TM) (PCCME(TM)) Service, Names Dora Ochsenbein Manager of Educational Planning 3Health News:Gullapalli & Associates Launches First-of-Its-Kind Patient Centered CME(TM) (PCCME(TM)) Service, Names Dora Ochsenbein Manager of Educational Planning 4Health News:New blood test greatly reduces false-positives in prostate cancer screening 2Health News:Craneware Supports Hospitals' Compliance and Upfront Collections with Accurate Estimates 2Health News:Craneware Supports Hospitals' Compliance and Upfront Collections with Accurate Estimates 3Health News:Craneware Supports Hospitals' Compliance and Upfront Collections with Accurate Estimates 4Health News:Spanish-Speaking OmniPod Customer Support Now Available Around-the-Clock 2Health News:Spanish-Speaking OmniPod Customer Support Now Available Around-the-Clock 3Health News:New Book Highlights Human Cost of FDA's Failure to Investigate Medical Devices 2
Blunt tipped forceps with tungsten carbide treated jaws for enhanced gripping and removal of large sized foreign bodies....
Blunt tipped forceps with entire interior surface of tip serrated. For general purpose membrane grasping (coarse membranes)....
The Tano Asymmetrical Microforceps features an offset tip which allows optimal visualization along the entire tip length. Versatile tip design targets ILM, fine epiretinal membranes and diabetic or P...
Microforceps : Eckardt End & Side Gripping Forceps...
Medicine Products: